Dutch payers are pragmatic, especially when discussing medical devices, isn’t it, Ron de Graff?

June 1, 2022

The market access process in the Netherlands can be very special, especially for medical devices. Besides standard reimbursement processes with evidence-based medicine assessments, there are also more pragmatic pathways available. How do these work and what needs to be considered before moving into the Dutch health care market? Listen to the insightful discussion of Dr. Stefan Walzer and the Dutch market access expert Ron de Graaff.



MAP – Market Access Podcast, is the first and only bi-weekly market access podcast provided by MArS. Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website

For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de

Episode 19 – Published June 1, 2022

Share This Story!